A DNA Based Biosensor Amplified With ZIF-8/Ionic Liquid Composite for Determination of Mitoxantrone Anticancer Drug: An Experimental/Docking Investigation.

1-butyl-3-methylimidazolium methanesulfonate ZIF-8 drug analysis ds-DNA biosensor mitoxantrone modified electrode

Journal

Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988

Informations de publication

Date de publication:
2020
Historique:
received: 28 06 2020
accepted: 03 08 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

An ultrasensitive DNA electrochemical biosensor based on the carbon paste electrode (CPE) amplified with ZIF-8 and 1-butyl-3-methylimidazolium methanesulfonate (BMIMS) was fabricated in this research. The DNA/BMIMS/ZIF-8/CPE was used for the selective determination of a mitoxantrone anticancer drug in aqueous solution, resulting in a good catalytic effect and a powerful ability for determining mitoxantrone. Also, the interaction of the mitoxantrone anticancer drug with guanine bases of ds-DNA was used as a powerful strategy in the suggested biosensor, which was confirmed with docking investigation. Docking study of mitoxantrone into the ds-DNA sequence showed the intercalative binding mode of mitoxantrone into the nitrogenous-based pairs of ds-DNA. The effective factors such as ds-DNA concentration, temperature, buffer types, and incubation time were also optimized for the fabricated mitoxantrone biosensor. The results showed that, under optimum conditions (T = 25°C; incubation time=12 min; pH= 4.8 acetate buffer solution and [DNA] = 50 mg/L), the DNA/BMIMS/ZIF-8/CPE could be used in mitoxantrone assay in a concentration ranging from 8.0 nM to 110 μM with a detection limit of 3.0 nM. In addition, recovery data between 99.18 and 102.08% were obtained for the determination of mitoxantrone in the injection samples using DNA/ZIF-8/BMIMF/CPE as powerful biosensors.

Identifiants

pubmed: 33195033
doi: 10.3389/fchem.2020.00814
pmc: PMC7606923
doi:

Types de publication

Journal Article

Langues

eng

Pagination

814

Informations de copyright

Copyright © 2020 Alizadeh, Azar, Mozaffari, Karimi-Maleh and Tamaddon.

Références

Biophys Chem. 2005 Aug 1;116(3):199-205
pubmed: 15893412
Science. 2008 Feb 15;319(5865):939-43
pubmed: 18276887
Biosens Bioelectron. 2017 Oct 15;96:1-7
pubmed: 28448855
Neurology. 2004 Dec 28;63(12 Suppl 6):S15-8
pubmed: 15623664
Cancer Chemother Pharmacol. 1983;10(3):187-91
pubmed: 6574828
Analyst. 2019 Sep 21;144(18):5504-5510
pubmed: 31389925
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:175-82
pubmed: 25280694
Neurology. 2010 Jan 5;74 Suppl 1:S41-6
pubmed: 20038762
Anticancer Res. 1987 Nov-Dec;7(6):1257-64
pubmed: 3327453
Food Chem. 2015 Oct 15;185:430-6
pubmed: 25952889
Mater Sci Eng C Mater Biol Appl. 2015 Dec 1;57:387-96
pubmed: 26354280
Biosens Bioelectron. 2020 Jan 1;147:111788
pubmed: 31671380
Analyst. 2017 Oct 7;142(19):3598-3604
pubmed: 28891579
CNS Drugs. 2004;18(6):379-96
pubmed: 15089110
Biosens Bioelectron. 1998 Oct 1;13(7-8):861-7
pubmed: 9828383
Chem Rec. 2020 Jul;20(7):682-692
pubmed: 31845511
Angew Chem Int Ed Engl. 2016 Jan 11;55(2):500-13
pubmed: 26783056

Auteurs

Marzieh Alizadeh (M)

Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Parviz Aberoomand Azar (PA)

Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Sayed Ahmad Mozaffari (SA)

Department of Chemical Technologies, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran.

Hassan Karimi-Maleh (H)

Laboratory of Nanotechnology, Department of Chemical Engineering, Quchan University of Technology, Quchan, Iran.

Ali-Mohammad Tamaddon (AM)

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Classifications MeSH